Elena S. Saganova

Elena S. Saganova

Auto-generated profile, based on publicly available information

Elena S. Saganova

Pavlov University

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2021 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
ESElena S. Saganova
Elena S. Saganova
IZIrina M. Zubina
Irina M. Zubina
EBEvdokia Bogdanova
Evdokia Bogdanova
OGOlga V. Galkina
Olga V. Galkina
VSVasilii G. Sipovskii
Vasilii G. Sipovskii
ASAleksei V. Smirnov
Aleksei V. Smirnov
Aim. To investigate the diagnostic value of biomarkers in assessing the severity of sclerotic and atrophic lesions in primary glomerulopathies. Materials and methods. One hundred patients were included in the study, according to the results of kidney biopsy in 9 (9%) cases minimal change disease was diagnosed, in 28 (28%) focal segmental glomerulosclerosis, in 26 (26%) membranous nephropathy and in 37 (37%) IgA nephropathy. The clinical course of nephropathy was evaluated, standard laboratory tests were performed, and urinary excretions of cystatin C, 1-microglobulin, 2-microglobulin and NGAL were measured. The degree of glomerulosclerosis was assessed quantitatively, tubulointerstitial sclerosis and tubular atrophy semiquantitatively. Results. According to the results of linear correlations and ROC-analysis, urinary excretion of cystatin C and 1-microglobulin had diagnostic value for early degree of tubulointerstitial sclerosis (cut-off value 319.9 and 10.94 mg/day, respectively). Urinary excretion of 2-microglobulin reflected the initial degree of tubalar atrophy (cut-off value of 0.224 mcg/day), as well as tubulointerstitial sclerosis of various degrees of severity (cut-off value 0.224 and 0.240 mkg/day). NGAL urinary excretion was the only marker of early degree of glomerulosclerosis with its excretion of more than 1445.4 ng/day and tubular atrophy, with a severity of 50% or more (cut-off value 4897.8 ng/day). Conclusion. A comprehensive assessment of sclerotic and atrophic lesions in the renal parenchyma, can be performed using a panel of traditional (GFR, proteinuria) and specific biomarkers (1-, 2-microglobulins, cystatin C, NGAL) to implement a comprehensive, personalized approach, as well as to assess the prognosis of nephropathy. In addition, the evaluation of the panel of different biomarkers can be used in those clinical situations where kidney biopsy can not be performed.

1 January 2013
Verified
Journal Article
Closed access
IPIa Iu Proletov
Ia Iu Proletov
ESE S Saganova
E S Saganova
OGO V Galkina
O V Galkina
IZI M Zubina
I M Zubina
EBEvdokia Bogdanova
Evdokia Bogdanova
ASA V Smirnov
A V Smirnov

1 May 2017 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
ESElena Saganova
Elena Saganova
OGOlga Galkina
Olga Galkina
VSVasiliy Sipovskii
Vasiliy Sipovskii
Alexander SmirnovAlexander Smirnov
Alexander Smirnov
INTRODUCTION AND AIMS: Glomerular filtration rate (GFR) is generally accepted as a best overall index of kidney function. The most common method to assess kidney function in patients with primary glomerulonephritis (GN) is estimated GFR (eGFR) based on serum creatinine. Creatinine-based formulas should be interpreted with caution due to impact of different non-GFR determinant especially in nephrotic syndrome, since tubular creatinine handling is altered in this condition. Our aim was to assess different equations of eGFR to predict tubulo-interstitial damage as a most powerful prognostic factor in progression of chronic kidney disease in patients with primary GN.

22 June 2024 in Neurology, Neuropsychiatry, Psychosomatics
Verified
Journal Article
Open access
PDF file
ISIa. B. Skiba
Ia. B. Skiba
APAlexey Polushin
Alexey Polushin
ESE. S. Saganova
E. S. Saganova
SSSokolov Sokolov
Sokolov Sokolov
Ekaterina PolyakovaEkaterina Polyakova
Ekaterina Polyakova
IVI. A. Vosnyuk
I. A. Vosnyuk
High lipoprotein(a) (LP(a)) level contributes as an independent risk factor to the development of cardiovascular diseases of atherosclerotic origin. The article contains data on the structural features of this particle, the genetic determination of its metabolism and content in blood plasma, and the pathogenic mechanisms of its proatherogenic, proinflammatory and prothrombotic effects. The authors analyzed epidemiological data on the frequency of elevated LP(a) levels in different population groups and its association with the risk of cardiovascular diseases. The data presented concern the indicators of LP(a) as a risk factor for the development of ischemic stroke (including recurrent stroke) and its individual pathogenetic subtypes, as well as the relationship between LP(a) levels and functional outcomes after cerebral accidents. Current recommendations for the treatment of patients with elevated LP(a) levels in the context of primary and secondary prevention of cardiovascular diseases are analyzed.

8 April 2026 in The Scientific Notes of the Pavlov University
Verified
Journal Article
Closed access
ESE. S. Saganova
E. S. Saganova
APAlexey Polushin
Alexey Polushin
IZIu. R. Zalyalov
Iu. R. Zalyalov
AKAlexandr Nicolaevich Kulikov
Alexandr Nicolaevich Kulikov
AKAlexander Kulagin
Alexander Kulagin
The incidence of autoimmune diseases is increasing worldwide. Systemic sclerosis (SSc) is more common in young adults and is characterized by extensive progressive fibrotic lesions of the skin and other organs. The rapidly progressive diffuse form of SSc can lead to short-term mortality in 30% of cases. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation (HDIT-AHSCT) has multiple immune-mediated effects that can reduce clinical manifestations and improve prognosis in patients with SSc. The method has been used for SSc since 1997. Approximately 900 transplant procedures for SSc have been performed within the registry of the European Society for Blood and Marrow Transplantation (EBMT). This paper analyzes the results of randomized clinical trials (ASSIST, ASTIS, SCOT) using HDIT-AHSCT in SSc. It presents patient group characteristics, conditioning regimens, and efficacy compared to standard therapies. The criteria and patient selection process, as well as indications and contraindications for the procedure, are also presented. This information can be used to further justify the expansion of care options for patients with SSc in the Russian Federation.

9 April 2025 in Regional blood circulation and microcirculation
Verified
Journal Article
Open access
PDF file
VSV. A. Shurakova
V. A. Shurakova
AKAlexandr Nicolaevich Kulikov
Alexandr Nicolaevich Kulikov
IPI. Yu. Panina
I. Yu. Panina
APAlexey Polushin
Alexey Polushin
YZYu. R. Zalyalov
Yu. R. Zalyalov
ЮЗЮ. Р. Залялов
Ю. Р. Залялов
Introduction. Infusion therapy, despite all its advantages, is not fully understood regarding its impact on the cardiovascular system when large volumes of fluid are used. Objective. To assess the response of the cardiovascular system to massive infusion load in 5 healthy individuals. Materials and Methods. The study included 5 healthy volunteers (2 men and 3 women), with a mean age of 31.6±5.3 years, mean weight of 73.25±15.8 kg, and mean body surface area of 1.83±0.2 m². The study protocol involved the administration of 0.9 % sodium chloride solution through a peripheral catheter for ≈10 hours during the daytime over 2 days, at a volume of 2.2 L/m² body surface area per day. Before the start of the experiment, as well as 48 hours (2 days) and 168 hours (7 days) after the start, all participants underwent measurements of body weight, blood pressure (BP), heart rate (HR), blood tests for NT-proBNP levels, and transthoracic echocardiography. Results. The study found no significant changes in BP, HR, and body weight. A significant increase in NT-proBNP level was noted, rising from 29.3±17.67 ng/ml to 295.4±136.1 ng/ml (p=0.018) after 48 hours of infusion, followed by a decrease (38.0±20.94 ng/ml, p=0.020) and normalization after 7 days. Additionally, after 48 hours, there was an increase in the volume of the left atrium (from 39.2±9.0 ml to 58.2±10.7 ml; p=0.003), basal size of the right ventricle (from 3.44±0.18 cm to 3.66±0.26 cm; p=0.020), and vertical size of the right atrium (from 4.12±0.24 cm to 4.56±0.37 cm; p=0.032), as well as an increase in the amplitude of tricuspid annulus systolic excursion (TAPSE) – from 2.5±0.27 cm to 2.94±0.25 cm; p=0.034) and the E/e’ index (from 3.87±0.52 to 4.83±0.35; p=0.015. Conclusion. Intravenous administration of large volumes of 0.9 %NaCL is associated with an enlargement of the right heart chambers, with enhanced contractility of the right ventricle, increased volume of the left atrium, elevated left ventricular filling pressure, and a marked increase in NT-proBNP. NT-proBNP level should be estimated outside of infusion therapy.